Early anti-TNF and surgery rates in ileocolonic CD

What is known

• A referenced study reports early biologic treatment decreases risk of surgery in Crohn's disease. ¹
• Population-based data cited in the same source found anti-TNF introduction did not reduce surgical rates but prolonged time from diagnosis to first resection, and did not produce expected declines in hospitalisation/resection. ¹
• A Danish trend analysis associated increased immunomodulator and biologic use with a reduced proportion requiring surgery, but whether this reflects true avoidance versus postponed resection is unclear. ²

What is unknown / caveats

• One cited reference reports early biologics reduce surgery risk while population-based series found no reduction in resection rates
• Reduced surgery proportion may reflect postponed rather than avoided resection
• No retrieved study directly compares early anti-TNF vs immunomodulator-alone strategies for surgery rate
• The supportive claim appears only as a citation title, not as extractable outcome data
• The LIR!C-related excerpts compare infliximab vs ileocecal resection, not early biologic vs immunomodulator
• The retrieved evidence cannot resolve whether early anti-TNF truly reduces surgery or merely delays it relative to immunomodulators alone.

References

1. Aratari A, Scribano ML, Pugliese D, Baccolini V, De Biasio F, Verna S, Morretta C, Festa S, Armuzzi A, Papi C. Crohn's disease after surgery: Changes in post-operative management strategies over time and their impact on long-term re-operation rate-A retrospective multicentre real-world study. Aliment Pharmacol Ther. 2024;59(12):1579-1588. PMID: 38616417.

2. [No authors listed]. The association between intensified medical treatment, time to surgery and ileocolic specimen length in Crohn's disease. Colorectal Dis. 2017;19(6):551-558. PMID: 27883259.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.